James L. Clements

Biography

James received his PhD from the University of Vermont (Cell and Molecular Biology) and pursued postdoctoral training at the Universities of Iowa and Pennsylvania. After an 8 year appointment in the Department of Immunology at Roswell Park Cancer Institute, James joined Athenex in 2008 to complement and expand existing expertise in the pre-clinical research programs. Prior to joining Athenex, James led active research programs in lymphocyte development, activation, and immune system function. Since joining the Athenex team, James has focused on advancing pre-clinical programs related to the main Athenex platforms, including conversion of intravenous to oral dosing formats for multiple drugs. These efforts include a broad range of activities, from designing in vitro assays to the management of GLP-compliant toxicology studies. James plays an active role in Athenex research operations based in Hong Kong and China, including the preparation of multiple successful grant applications to support Athenex R&D initiatives in Asia.

Research Interest

 Cancer